Clinical trial
A Study of LY3437943 in Participants With Type 2 Diabetes
NCT04867785
Study timeline
Study start (actual)2021-05-13Date precision: day
Registry last updated2023-07-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
HoustonTexas, United States2DallasTexas, United States1PittsburghPennsylvania, United States1San DiegoCalifornia, United States1TampaFlorida, United States1GreenvilleSouth Carolina, United States1TacomaWashington, United States1Fort WorthTexas, United States1San JuanPuerto Rico1FresnoCalifornia, United States1Walnut CreekCalifornia, United States1FargoNorth Dakota, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04867785 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.